Organon & Co. (OGN) Social Stream



Organon & Co. (OGN): $33.54

-0.15 (-0.45%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Organon & Co (OGN) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Organon & Co.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
5 $48 $35 $41.8 $33.69 24.07%

The Trend in the Analyst Price Target


Over the past 15 days, OGN's average price target has gone up $1.47.

OGN reports an average of 25.29% for its upside potential over the past 98 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-19 5 48 35 41.80 34.03 22.83%
2021-09-18 5 48 35 41.80 34.03 22.83%
2021-09-11 5 48 35 41.80 33.88 23.38%
2021-09-04 6 48 33 40.33 35.61 13.25%
2021-08-28 5 48 33 39.80 34.25 16.2%
2021-08-14 5 48 33 37.80 34.21 10.49%
2021-08-07 5 48 33 38.20 29.50 29.49%
2021-08-05 5 48 33 38.20 29.56 29.23%
2021-08-01 5 48 33 38.20 29.01 31.68%
2021-07-24 5 48 33 38.20 29.80 28.19%
2021-07-17 4 48 33 39.00 28.87 35.09%
2021-07-10 4 48 33 39.00 30.10 29.57%
2021-07-03 4 48 33 39.00 30.86 26.38%
2021-06-26 4 48 33 39.00 30.19 29.18%
2021-06-13 4 48 33 39.00 29.65 31.53%

OGN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.57 2 2 3 0 0 7

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • OGN has a higher upside potential (average analyst target price relative to current price) than 14.83% of Pharmaceutical Products stocks.
  • Organon & Co's average analyst price target is greater than 73.57% of Pharmaceutical Products stocks.
  • The number of analysts covering the stock of OGN is higher than 30.47% of stocks in the mid market cap category.
  • The variance in analysts' estimates of OGN is less than 63.36% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Organon & Co are PBH, RVMD and RUBY.

Make investment decisions regarding OGN using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.1136 seconds.